Awards

Medipixel is being recognized
by prestigious institutions
both domestically and internationally
for its innovative medical AI technology.

Medipixel Named a Judges’ Winner at ACC.26 Innovation Pitch Challenge

Innovation Award from the Korean-German Chamber of Commerce and Industry

Selected for Top 10 Cross-Ministerial Medical Device Projects of 2024

The winner in the 2023 MedTech Innovator

Medipixel selected for the third consecutive year in the AI Startup 100

The winner in the MICCAI 2023 Challenge

Achievement

Medipixel Named a Judges’ Winner at ACC.26 Innovation Pitch Challenge
2026. 03. 28
Medipixel was named a Judges’ Winner at the ACC.26 Innovation Pitch Challenge. The company presented its vision for a Continuous Intelligence Platform that integrates morphological assessment and physiological evaluation to support precise decision-making in coronary interventions.
More News
Medipixel Named to TIME’s World’s Top HealthTech Companies 2025
2025. 09. 18
Medipixel was named to TIME’s World’s Top HealthTech Companies 2025, selected by TIME and Statista, recognizing its competitiveness as a global healthtech company in AI and data analytics.
More News
Commissioner's Award from the Korean Intellectual Property Office for Patent-Driven R&D
2024. 12. 23
The Patent-Driven R&D program is a government initiative that uses intellectual property information as the foundation for research and development strategies, guiding companies to secure core patents. Medipixel received the Commissioner's Award in recognition of our outstanding achievements in this area.
Excellence Award at the 2nd AI Trustworthiness Awards
2024. 11. 24
At the AI Trustworthiness Awards organized by the Ministry of Science and ICT, our MPXA solution was once again recognized for its exceptional reliability as an artificial intelligence product in healthcare.
Innovation Award from the Korean-German Chamber of Commerce and Industry
2024. 11. 08
The Korean-German Chamber of Commerce and Industry (KGCCI) recognized Medipixel at their Innovation Awards for creating significant value through innovative ideas and business strategies in the Korean market.
Named to Forbes Korea AI 50 for 2024
2024. 03. 23
Medipixel was selected for the prestigious "Forbes Korea AI 50" in the Bio/Healthcare category, following a comprehensive evaluation of our management performance, leadership capabilities, and global market potential.
Selected for Top 10 Cross-Ministerial Medical Device Projects of 2024
2024. 03. 06
Medipixel was named to the 'Top 10 Cross-Ministerial Projects' in recognition of our effective research methodologies, significant impact on healthcare technology, and broader socioeconomic contributions.
The winner in the 2023 MedTech Innovator
2023. 12. 06
By winning the top prize at the 2023 MedTech Innovator Asia Pacific hosted by the renowned MedTech, our global business potential has once again been acknowledged.
More News
Selected for CB Insights' Digital Health 50
2023. 12. 05
By being the sole representative among Korean companies in the 2023 Digital Health 50 announced by the global market research firm CB Insights, Medipixel's technological prowess and business acumen have once again been recognized at a global level.
More News
Medipixel selected for the third consecutive year in the AI Startup 100
2023. 10. 26
We have been selected for the third consecutive year in the KOREA AI STARTUP 100, recognizing the top 100 startups in South Korea with the highest potential for artificial intelligence technology and growth.
The winner in the MICCAI 2023 Challenge
2023. 10. 12
Medipixel won the cardiovascular medical artificial intelligence algorithm competition held at MICCAI, the world's most prestigious medical imaging conference. This victory once again acknowledges the excellence of Medipixel's artificial intelligence technology.
More News
Recipient of the Minister of Science and ICT Award in recognition of excellence
2023. 04. 19
The project titled 'Development of an Automated System for Diagnosing Cardiovascular Diseases and Recommending Intervention Tools using AI,' which we carried out for two years, has been recognized as an exceptional project and has been awarded the Minister of Science and ICT Award.
More News
Recognition as one of the AI + X Top 100 Companies
2023. 01. 30
Medipixel has been selected as one of the '2023 Emerging AI+X Top 100' companies chosen by the Intelligence Information Industry Association in January 2023. Moving forward, we at Medipixel will continue to lead future innovation by integrating artificial intelligence technology into healthcare.
Designation as one of the National Top 1000 Innovation Enterprises
2021. 05. 03
We have been selected as one of the national representatives among the Innovation SMEs, recognized for the innovativeness and growth potential of our technology and products, by the Minister of SMEs and Startups in the Innovation SMEs National Top 1000.
First place in the Big-Star Problem Solver Platform Competition
2020. 12. 01
We clinched the championship in the 'AI-based Analysis of the Patient Condition' category at the Big-Star Problem Solver Platform Competition, a new cooperative model between large corporations and startups hosted by the Ministry of SMEs and Startups.
More News
First place in the Johnson & Johnson QuickFire Challenge
2018. 11. 14
We won the Robotics & Digital Surgery category of the QuickFire Challenge, a global competition hosted by Johnson & Johnson, reaffirming the innovative nature of our business model once again.
More News

Certification

MPFFR Selected as a New Health Technology Assessment Deferral Technology
2026. 03. 13
MPFFR was selected as a New Health Technology Assessment Deferral technology by the National Evidence-based Healthcare Collaborating Agency (NECA), establishing a foundation for clinical adoption while generating real-world clinical evidence.
More News
Angiography-Based FFR Measurement Technology Receives NET Certification
2025. 07. 09
Medipixel’s angiography-based fractional flow reserve (FFR) measurement technology received New Excellent Technology (NET) certification designated by the Ministry of Health and Welfare, recognizing its technological excellence and commercialization potential.
MDSAP(Medical Device Single Audit Program) Certified
2024. 12. 11
Medipixel has obtained certification under the Medical Device Single Audit Program (MDSAP), which is recognized by regulatory authorities in the United States, Canada, Brazil, Australia, and Japan. This achievement confirms that our quality management system meets international standards and significantly strengthens our position in the global medical device market.
Designated as an Innovative Product by the Korean Government
2024. 11. 27
Our MPXA solution has been officially designated as an Innovative Product by the Ministry of SMEs and Startups. This recognition supports our commitment to enhancing efficiency in clinical settings and improving patient safety..
Certified in Intellectual Property Management
2024. 11. 12
Medipixel has received the Intellectual Property Management Certification from the Korean Intellectual Property Office. This certification acknowledges our strategic approach to leveraging intangible assets—including patents, brand assets, and designs—as core elements of our business strategy to drive innovation and create value.
Certified as a Global IP Star Company
2024. 11. 06
Medipixel has been designated as a Global IP Star Company by the Korean Intellectual Property Office in recognition of our ongoing efforts to secure intellectual property rights both domestically and internationally, including in the United States and Europe, based on our competitive R&D capabilities.
Certified as a Technology Innovation-type Small and Medium Enterprise (Inno-Biz)
2024. 03. 13
Medipixel has earned the Inno-Biz certification for technology innovation excellence from the Ministry of SMEs and Startups. We remain committed to developing groundbreaking medical AI solutions through ongoing R&D and enhancing the global reputation of Korean medical technology.
Attainment of ISO 13485 certification
2023. 12. 08
We have obtained the ISO 13485 certification, an international standard for quality management systems in medical devices. Moving forward, we aim to enter the global medical device market by maintaining the highest level of quality management.
Successful completion of the GMP routine inspection
2023. 11. 10
After three years of continuous quality management following the initial GMP certification in 2020, we have successfully renewed our GMP certification.
Technical Evaluation Excellence Certification (NICE Information Service)
2023. 08. 01
In a technical assessment conducted by NICE Evaluation & Information, we have been awarded the investment-grade technical evaluation rating of TI-2 (Excellent), receiving an evaluation stating, 'With excellent technological prowess and growth potential in a promising market, the future growth prospects are exceptionally high.
Medipixel selected for U.S. Market Entry Program
2023. 07. 11
We have been selected for the U.S. Market Adoption Program organized by the Small and Medium Business Administration and MATTER in the United States, enabling us to collaborate with UChicago Medicine and other U.S. hospitals for clinical partnerships.
Designated as an Occupant Enterprise at the U.S. C&D Incubation Center
2023. 04. 03
We have been selected as a resident company at the C&D Incubation Center supported by South Korea Health Industry Development Institute. We anticipate this as a stepping stone to establish a foothold in the U.S. market, creating opportunities for market entry and partnerships in the United States.
Agreement for Suitability Assessment at Seoul National University Hospital
2021. 06. 17
We have entered into an agreement with Seoul National University Hospital for usability assessment. Through the enhancement of user-friendliness, we aim not only to improve efficiency and user satisfaction but also to ensure the highest level of safety.